Tokyo, Japan

Yasuo Nishii

This inventor holds 2 USPTO granted patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1982.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yasuo Nishii: Innovator in Immunological Function Management

Introduction

Yasuo Nishii is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunology, particularly in the management of autoimmune diseases and renal disorders. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Nishii's latest patents include a method for suppressing abnormal rise in immunological function and an agent for its treatment. This method involves administering cholecalciferol or its derivative to patients suffering from an abnormal rise in immunological function, which can lead to various autoimmune diseases. The agent developed contains this compound as an active ingredient, making it useful not only for treatment but also for preventing graft rejection. Another significant patent focuses on inhibiting the lowering of immunological function in patients with serious renal disorders, such as chronic renal failure or uremia, by administering 1.alpha.-hydroxycholecalciferol.

Career Highlights

Yasuo Nishii is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at this company has allowed him to focus on innovative solutions for complex health issues.

Collaborations

Nishii has collaborated with notable colleagues, including Hideo Miyakoshi and Yoshihei Hirasawa. Their combined expertise has contributed to the advancement of research in immunological functions.

Conclusion

Yasuo Nishii's innovative work in immunology showcases his dedication to improving patient outcomes through scientific advancements. His patents reflect a commitment to addressing critical health challenges, making him a noteworthy figure in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…